12
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Gabexate Mesilate (FOY) Inhibition of Amylase and Phospholipase A2 Activity in Sow Pancreatic Juice

, , , , , , & show all
Pages 345-351 | Published online: 20 Jul 2010

REFERENCES

  • Imrie CW, Blumgart L. Acute pancreatitis: A prospective study on some factors of mortality. Bull Soc Int Chir. 1975;6:601–610.
  • Freise J, Magerstedt P, Schmidt K. Inhibition of phospholi-pase A2 by gabexate mesilate, camostate and aprotinine. Enzyme. 1983;30:209–212.
  • Trapnell JE, RigbyCC, Talbot CH, Duncan EH. A controlled trial of Trasylol in the treatment of acute pancreatitis. Br J Surg. 1974;61(3):177–182.
  • Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O’Neill J, Blumgart LH. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978;65:337–341.
  • Kayama K, Yoshimura H. Inhibitory effects of Foy on various proteases. Gendai Iryo (Current Medicine). 1974;6(8):1010–1015.
  • Tamura Y, Hirado M, Okamura K, Minato Y, Fujii S. Synthetic inhibitors of trypsin, kallicrein, thrombin, Or and C1 esterase. Biochim Biophys Acta. 1977;484:417–422.
  • Maramatzu M, Fujii S. Inhibitory effects of omega-guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin. Biochim Biophys Acta. 1972;268:221–228.
  • Okegawa X Fujita T, Yamamoto Y, Nakai H, Miyamoto K, Matsumoto K, Tani S. Effects of FOY on experimental acute pancreatitis. CurrMed. 1974;6:1–10.
  • Wakayama T, Itoh T, Shibayama K, Idezuki Y Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs. Am J Gastroenterol. 1989;84(3):272–278.
  • Keim K, Goke B. Pancreatic secretion in the rat influenced by the low molecular weight serine proteinase inhibitor gabexate mesilate. Eur J Clin Invest. 1986; 16: 519–525.
  • Harada H, Miyake H, Ochi K, Tanaka J, «¡mura I. Clinical trial with a protease inhibitor gabexate mesilate in acute pancreatitis. Int J Pancreatol. 1991;9:75–79.
  • Pederzoli P, Cavallini G, Falconi M, Bassi C. Gabexate mesilate vs aprotinin in human acute pancreatitis. Int J Pancreatol. 1993;2:117–124.
  • Buchler M, Malfertheiner P, Uhi W, Scholmerich J, Stockmann F, Adler G, Gaus W, Rolle K, Beger HG. Gabexate mesilate in human acute pancreatitis. Gastroenterology. 1993; 104:1165–1170.
  • Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Di Francesco V. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996;335:919–923.
  • Freise J, Schmidt FW, Magerstedt P, Schmid K. Gabexate mesilate and camostate: New inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis. Clin Biochem. 1985;18(4):224–229.
  • Wisner JR, Renner IG, Grendel JH, Niederau C, Ferrell LD. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat. Pancreas. 1987;2(2):181–186.
  • Gõke B, Stockmann F, Müller R, Lankisch PG, Creutzfeldt W. Effect of a specific serine protease inhibitor on the rat pancreas: Systemic administration of camostate and exocrine pancreatic secretion. Digestion. 1984;30:171–178.
  • Ristkari SK, Ramo OJ, Kiviniemi H, Grohn P, Mahlberg K, Mokka RE. The effect of gabexate mesilate on the outcome of acute hemorrhagic pancreatitis in pigs. Res Exp Med. 1989; 189(1): 1–8.
  • Dennis EA. History, classification, structure and function of phospholipase A2. Prog Surg. 1997;24:1–7.
  • Gronroos JM, Nevalainen TJ. Phospholipase A2 in acute pancreatitis: Clinical value of phospholipase A2 measurements. Prog Surg. 1997;24:182–186.
  • Hoffmann GE, Schmidt D, Bastían B, Guder WG. Photometric determination of phospholipase A. J Clin Chem Clin Biochem. 1986;24(11):871–875.
  • Di Giovannadrea R, Diana L, Fiori M, Ferretti E, Foglietta G, Caronna R, Sevenni G. Determination of ethyl-p-hydroxybenzoate in sow pancreatic juice by reversed-phase high-performance liquid chromatography. J Chromatogr. 2001;751:365–369.
  • Kimura W, Secknus R, Fischbach W, Mossner J. Role of phospholipase A2 in pancreatic acinar cell damage and possibilities of inhibition: Studies with isolated rat pancreatic acini. Pancreas. 1993;8(1):70–79.
  • Schadlich HR, Buchler M, Beger HG. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate. Klin Wochenschr. 1989;67(3): 160–162.
  • Dobosz M, Sledzinski Z, Basinski A, Stanek A, Babicki A, Wajda Z. Effect on hemodynamics of therapeutic infusion of gabexate mesilate (FOY) in experimental acute pancreatitis. Res Exp Med. 1989;189:77–84.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.